
LINK . SPRINGER . COM {
}
Title:
EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression | Molecular Cancer
Description:
Background The ATLANTIC trial reported that higher PD-L1 expression in tumors was involved in a higher objective response in patients with EGFR+/ALK+ non-small cell lung cancer (NSCLC), indicating the possibility of anti-PD-1/PD-L1 therapy as a third-line (or later) treatment for advanced NSCLC. Therefore, the determination of status and regulatory mechanisms of PD-L1 in EGFR mutant NSCLC before and after acquired EGFR-TKIs resistance are meaningful. Methods The correlation among PD-L1, c-MET, and HGF was analyzed based on TCGA datasheets and paired NSCLC specimens before and after acquired EGFR-TKI resistance. EGFR-TKI resistant NSCLC cells with three well-known mechanisms, c-MET amplification, hepatocyte growth factor (HGF), and EGFR-T790M, were investigated to determinate PD-L1 expression status and immune escape ability. PD-L1-deleted EGFR-TKIs sensitive and resistant cells were used to evaluate the immune escape ability of tumors in mice xenograft models. Results Positive correlations were found among PD-L1, c-MET, and HGF, based on TCGA datasheets and paired NSCLC specimens. Moreover, the above three resistant mechanisms increased PD-L1 expression and attenuated activation and cytotoxicity of lymphocytes in vitro and in vivo, and downregulation of PD-L1 partially restored the cytotoxicity of lymphocytes. Both MAPK and PI3K pathways were involved in the three types of resistance mechanism-induced PD-L1 overexpression, whereas the NF-kappa B pathway was only involved in T790M-induced PD-L1 expression. Conclusions HGF, MET-amplification, and EGFR-T790M upregulate PD-L1 expression in NSCLC and promote the immune escape of tumor cells through different mechanisms.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {š}
- Science
- Education
- Health & Fitness
Content Management System {š}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {š}
What is the average monthly size of link.springer.com audience?
š Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {šø}
We can't figure out the monetization strategy.
Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.
Keywords {š}
pdl, cells, expression, nsclc, cancer, egfrtki, resistant, pubmed, lung, cmet, article, egfr, resistance, google, scholar, hgf, patients, cell, cas, immune, figure, egfrtkis, pcr, additional, fig, treatment, pathway, mutant, amplification, mapk, tumour, file, mutation, wang, mechanisms, signaling, results, activation, gefitinib, acquired, growth, pathways, nfkappa, tumours, human, lymphocytes, percentage, pikakt, escape, involved,
Topics {āļø}
pd-l1-deleted egfr-tkis sensitive egfr-tkiĀ resistant lung cancer pd-1/pd-l1 axis plays pd-1/pd-l1 therapies require c-met amplification-induced upregulation c-met si-rnas downregulate anti-pd-1/pd-l1 inhibitors pd-l1-induced primary resistance anti-pd-l1 antibodies restores anti-pd-1/pd-l1 therapies t790m-induced pd-l1 expression hgf-mediated pd-l1 expression egfr-tkiĀ resistant mechanisms related egfr-tkiĀ resistant nsclc cells egfr-related pd-l1 expression hgf-induced pd-l1 upregulation pd-1/pd-l1 immune checkpoint anti-pd-l1 monoclonal antibody hgf-induced pd-l1 expression anti-pd-1/pd-l1 therapy egfr-tkisĀ resistant nsclc tumours egfr+/c-met+ mutant nsclc egfr+/c-metā mutant nsclc crispr-cas9 knockout lentiviruses anti-pd-l1 antibodies restored egfr-tkisĀ resistant nsclc cells pi3k/akt/nf-kappab signaling pathway pc-9rpd-l1- tumours responded small-cell lung cancer crispr-cas9 knockout lentivirus cd3ācd16+cd56+ nk cells egfr-tki resistant nsclc egfr-tkiĀ resistant nsclc pd-1/pd-l1 inhibitors acquiring egfr-tki resistance generated egfr-tki sensitive pd-l1 expression induced dual pi3k/mtor inhibitors pc-9r pd-l1- xenografts c-jun si-rna generation egfr-tkisĀ resistance [10] egfr-tkis resistant nsclc egfr-tkisĀ resistant nsclc upregulate pd-l1 expression members including c-jun c-met sirna combined pc-9rpd-l1- tumours shows induce egfr-tkis resistance acquiredĀ egfr-tki resistance acquired egfr-tki resistance
Questions {ā}
- ATLANTIC: a sea change in immunotherapy for oncogene-driven lung cancer?
- Does c-met remain a rational target for therapy in patients with EGFR TKI-resistant non-small cell lung cancer?
- What does PD-L1 positive or negative mean?
- Org/study?
Schema {šŗļø}
WebPage:
mainEntity:
headline:EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
description:The ATLANTIC trial reported that higher PD-L1 expression in tumors was involved in a higher objective response in patients with EGFR+/ALK+ non-small cell lung cancer (NSCLC), indicating the possibility of anti-PD-1/PD-L1 therapy as a third-line (or later) treatment for advanced NSCLC. Therefore, the determination of status and regulatory mechanisms of PD-L1 in EGFR mutant NSCLC before and after acquired EGFR-TKIs resistance are meaningful. The correlation amongĀ PD-L1, c-MET, and HGF was analyzed based on TCGA datasheets and paired NSCLC specimens before and after acquiredĀ EGFR-TKI resistance. EGFR-TKI resistant NSCLC cells with three well-known mechanisms, c-MET amplification, hepatocyte growth factor (HGF), and EGFR-T790M, were investigated to determinate PD-L1 expression status and immune escape ability. PD-L1-deleted EGFR-TKIs sensitive and resistant cells were used to evaluate the immune escape ability of tumors in mice xenograft models. Positive correlations were found amongĀ PD-L1, c-MET, and HGF, based on TCGA datasheets and paired NSCLC specimens. Moreover, the above three resistant mechanisms increased PD-L1 expression and attenuated activation and cytotoxicity of lymphocytes in vitro and in vivo, and downregulation of PD-L1 partially restored the cytotoxicity of lymphocytes. Both MAPK and PI3K pathways were involved in the three types of resistance mechanism-induced PD-L1 overexpression, whereas the NF-kappa B pathway was only involved in T790M-induced PD-L1 expression. HGF, MET-amplification, and EGFR-T790M upregulate PD-L1 expression in NSCLC and promote the immune escape of tumor cells through different mechanisms.
datePublished:2019-11-20T00:00:00Z
dateModified:2019-11-20T00:00:00Z
pageStart:1
pageEnd:14
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12943-019-1073-4
keywords:
PD-L1
EGFR-TKIs resistance
Signaling pathways
Lung cancer
Immunotherapy
Cancer Research
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig6_HTML.png
isPartOf:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:18
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Shunli Peng
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Rong Wang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Xiaojuan Zhang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Yueyun Ma
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Longhui Zhong
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Ke Li
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Center for Clinical Medicine Research, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Akihiro Nishiyama
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
type:Person
name:Sachiko Arai
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
type:Person
name:Seiji Yano
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Wei Wang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
description:The ATLANTIC trial reported that higher PD-L1 expression in tumors was involved in a higher objective response in patients with EGFR+/ALK+ non-small cell lung cancer (NSCLC), indicating the possibility of anti-PD-1/PD-L1 therapy as a third-line (or later) treatment for advanced NSCLC. Therefore, the determination of status and regulatory mechanisms of PD-L1 in EGFR mutant NSCLC before and after acquired EGFR-TKIs resistance are meaningful. The correlation amongĀ PD-L1, c-MET, and HGF was analyzed based on TCGA datasheets and paired NSCLC specimens before and after acquiredĀ EGFR-TKI resistance. EGFR-TKI resistant NSCLC cells with three well-known mechanisms, c-MET amplification, hepatocyte growth factor (HGF), and EGFR-T790M, were investigated to determinate PD-L1 expression status and immune escape ability. PD-L1-deleted EGFR-TKIs sensitive and resistant cells were used to evaluate the immune escape ability of tumors in mice xenograft models. Positive correlations were found amongĀ PD-L1, c-MET, and HGF, based on TCGA datasheets and paired NSCLC specimens. Moreover, the above three resistant mechanisms increased PD-L1 expression and attenuated activation and cytotoxicity of lymphocytes in vitro and in vivo, and downregulation of PD-L1 partially restored the cytotoxicity of lymphocytes. Both MAPK and PI3K pathways were involved in the three types of resistance mechanism-induced PD-L1 overexpression, whereas the NF-kappa B pathway was only involved in T790M-induced PD-L1 expression. HGF, MET-amplification, and EGFR-T790M upregulate PD-L1 expression in NSCLC and promote the immune escape of tumor cells through different mechanisms.
datePublished:2019-11-20T00:00:00Z
dateModified:2019-11-20T00:00:00Z
pageStart:1
pageEnd:14
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s12943-019-1073-4
keywords:
PD-L1
EGFR-TKIs resistance
Signaling pathways
Lung cancer
Immunotherapy
Cancer Research
Oncology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig5_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_Fig6_HTML.png
isPartOf:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:18
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Shunli Peng
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Rong Wang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Xiaojuan Zhang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Yueyun Ma
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Longhui Zhong
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Ke Li
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Center for Clinical Medicine Research, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
type:Person
name:Akihiro Nishiyama
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
type:Person
name:Sachiko Arai
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
type:Person
name:Seiji Yano
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Wei Wang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Molecular Cancer
issn:
1476-4598
volumeNumber:18
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
name:Nanfang Hospital, Southern Medical University
address:
name:Center for Clinical Medicine Research, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Shunli Peng
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Rong Wang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Xiaojuan Zhang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Yueyun Ma
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Longhui Zhong
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Ke Li
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Center for Clinical Medicine Research, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
name:Akihiro Nishiyama
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
name:Sachiko Arai
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
name:Seiji Yano
affiliation:
name:Cancer Research Institute, Kanazawa University
address:
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Wei Wang
affiliation:
name:Nanfang Hospital, Southern Medical University
address:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
name:Center for Clinical Medicine Research, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
name:Divisions of Medical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan
name:Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Peopleās Republic of China
External Links {š}(196)
- https://www.springernature.com/gp/authors's revenue stream
- https://link.springernature.com/home/'s revenue stream
- What are the total earnings of https://order.springer.com/public/cart?
- What is the monthly revenue of https://www.springernature.com/gp/open-science/about/the-fundamentals-of-open-access-and-open-research?
- https://molecular-cancer.biomedcentral.com/about's total income per month
- How much revenue does https://submission.nature.com/new-submission/12943/3 generate?
- What's the profit of http://www.cbioportal.org/study?id=luad_tcga#summary?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30620402 each month?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%2C%202019&journal=CA%20Cancer%20J%20Clin&volume=69&pages=7-34&publication_year=2019&author=Siegel%2CRL&author=Miller%2CKD
- See how much https://doi.org/10.1056%2FNEJMoa0810699 makes per month
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19692680 pull in monthly?
- How much income does http://scholar.google.com/scholar_lookup?&title=Gefitinib%20or%20carboplatin-paclitaxel%20in%20pulmonary%20adenocarcinoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa0810699&volume=361&pages=947-957&publication_year=2009&author=Mok%2CTS&author=Wu%2CYL&author=Thongprasert%2CS&author=Yang%2CCH&author=Chu%2CDT&author=Saijo%2CN&author=Sunpaweravong%2CP&author=Han%2CBH&author=Margono%2CB&author=Ichinose%2CY have?
- Profit of https://doi.org/10.1200%2FJCO.2012.44.2806
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23816960?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Phase%20III%20study%20of%20afatinib%20or%20cisplatin%20plus%20pemetrexed%20in%20patients%20with%20metastatic%20lung%20adenocarcinoma%20with%20EGFR%20mutations&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2012.44.2806&volume=31&pages=3327-3334&publication_year=2013&author=Sequist%2CLV&author=Yang%2CJC&author=Yamamoto%2CN&author=O%27Byrne%2CK&author=Hirsh%2CV&author=Mok%2CT&author=Geater%2CSL&author=Orlov%2CS&author=Tsai%2CCM&author=Boyer%2CM generate?
- How much cash flow does https://doi.org/10.1097%2FMD.0000000000001263 have monthly?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=BIM%20gene%20polymorphism%20lowers%20the%20efficacy%20of%20EGFR-TKIs%20in%20advanced%20nonsmall%20cell%20lung%20Cancer%20with%20sensitive%20EGFR%20mutations%3A%20a%20systematic%20review%20and%20meta-analysis&journal=Medicine%20%28Baltimore%29&doi=10.1097%2FMD.0000000000001263&volume=94&publication_year=2015&author=Huang%2CWF&author=Liu%2CAH&author=Zhao%2CHJ&author=Dong%2CHM&author=Liu%2CLY&author=Cai%2CSX?
- Monthly income for https://doi.org/10.1016%2Fj.lungcan.2009.11.020
- Get to know http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20022659's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=KRAS%20mutations%20and%20resistance%20to%20EGFR-TKIs%20treatment%20in%20patients%20with%20non-small%20cell%20lung%20cancer%3A%20a%20meta-analysis%20of%2022%20studies&journal=Lung%20Cancer&doi=10.1016%2Fj.lungcan.2009.11.020&volume=69&pages=272-278&publication_year=2010&author=Mao%2CC&author=Qiu%2CLX&author=Liao%2CRY&author=Du%2CFB&author=Ding%2CH&author=Yang%2CWC&author=Li%2CJ&author=Chen%2CQ earn?
- How much money does https://doi.org/10.1177%2F1753465816670498 make?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27784815
- What's the financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933598?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Osimertinib%20in%20the%20treatment%20of%20patients%20with%20epidermal%20growth%20factor%20receptor%20T790M%20mutation-positive%20metastatic%20non-small%20cell%20lung%20cancer%3A%20clinical%20trial%20evidence%20and%20experience&journal=Ther%20Adv%20Respir%20Dis&doi=10.1177%2F1753465816670498&volume=10&pages=549-565&publication_year=2016&author=Sullivan%2CI&author=Planchard%2CD
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27259997?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239477?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20coexistence%20of%20MET%20over-expression%20and%20an%20EGFR%20T790M%20mutation%20is%20related%20to%20acquired%20resistance%20to%20EGFR%20tyrosine%20kinase%20inhibitors%20in%20advanced%20non-small%20cell%20lung%20cancer&journal=Oncotarget&volume=7&pages=51311-51319&publication_year=2016&author=Gou%2CLY&author=Li%2CAN&author=Yang%2CJJ&author=Zhang%2CXC&author=Su%2CJ&author=Yan%2CHH&author=Xie%2CZ&author=Lou%2CNN&author=Liu%2CSY&author=Dong%2CZY produce monthly?
- https://doi.org/10.1016%2Fj.ctrv.2017.10.003 income
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29121501
- How much profit does http://scholar.google.com/scholar_lookup?&title=Does%20c-met%20remain%20a%20rational%20target%20for%20therapy%20in%20patients%20with%20EGFR%20TKI-resistant%20non-small%20cell%20lung%20cancer%3F&journal=Cancer%20Treat%20Rev&doi=10.1016%2Fj.ctrv.2017.10.003&volume=61&pages=70-81&publication_year=2017&author=Wu%2CYL&author=Soo%2CRA&author=Locatelli%2CG&author=Stammberger%2CU&author=Scagliotti%2CG&author=Park%2CK generate?
- How much does https://doi.org/10.1016%2Fj.jtho.2018.05.024 rake in every month?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29857056 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=EGFR%20L792H%20and%20G796R%3A%20two%20novel%20mutations%20mediating%20resistance%20to%20the%20third-generation%20EGFR%20tyrosine%20kinase%20inhibitor%20Osimertinib&journal=J%20Thorac%20Oncol&doi=10.1016%2Fj.jtho.2018.05.024&volume=13&pages=1415-1421&publication_year=2018&author=Zhang%2CQ&author=Zhang%2CXC&author=Yang%2CJJ&author=Yang%2CZF&author=Bai%2CY&author=Su%2CJ&author=Wang%2CZ&author=Zhang%2CZ&author=Shao%2CY&author=Zhou%2CQ bring in each month?
- How much does https://doi.org/10.21037%2Fatm.2016.12.09 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28164089 pull in?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5253284 have monthly?
- How much profit does http://scholar.google.com/scholar_lookup?&title=MET%2FHGF%20pathway%20activation%20as%20a%20paradigm%20of%20resistance%20to%20targeted%20therapies&journal=Ann%20Transl%20Med&doi=10.21037%2Fatm.2016.12.09&volume=5&publication_year=2017&author=Ko%2CB&author=He%2CT&author=Gadgeel%2CS&author=Halmos%2CB generate?
- Profit of https://doi.org/10.1056%2FNEJMoa1200694
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22658128 make?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563263?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Safety%20and%20activity%20of%20anti-PD-L1%20antibody%20in%20patients%20with%20advanced%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1200694&volume=366&pages=2455-2465&publication_year=2012&author=Brahmer%2CJR&author=Tykodi%2CSS&author=Chow%2CLQ&author=Hwu%2CWJ&author=Topalian%2CSL&author=Hwu%2CP&author=Drake%2CCG&author=Camacho%2CLH&author=Kauh%2CJ&author=Odunsi%2CK
- How much does https://doi.org/10.1056%2FNEJMoa1501824 bring in each month?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25891174
- How much does http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20for%20the%20treatment%20of%20non-small-cell%20lung%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1501824&volume=372&pages=2018-2028&publication_year=2015&author=Garon%2CEB&author=Rizvi%2CNA&author=Hui%2CR&author=Leighl%2CN&author=Balmanoukian%2CAS&author=Eder%2CJP&author=Patnaik%2CA&author=Aggarwal%2CC&author=Gubens%2CM&author=Horn%2CL bring in each month?
- What's the income generated by https://doi.org/10.1158%2F1078-0432.CCR-16-2554 each month?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28039262 earning monthly?
- How much profit is http://scholar.google.com/scholar_lookup?&title=Potential%20predictive%20value%20of%20TP53%20and%20KRAS%20mutation%20status%20for%20response%20to%20PD-1%20blockade%20immunotherapy%20in%20lung%20adenocarcinoma&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-16-2554&volume=23&pages=3012-3024&publication_year=2017&author=Dong%2CZY&author=Zhong%2CWZ&author=Zhang%2CXC&author=Su%2CJ&author=Xie%2CZ&author=Liu%2CSY&author=Tu%2CHY&author=Chen%2CHJ&author=Sun%2CYL&author=Zhou%2CQ making per month?
- How much revenue does https://doi.org/10.1016%2FS0140-6736%2815%2901281-7 produce monthly?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26712084?
- How much does http://scholar.google.com/scholar_lookup?&title=Pembrolizumab%20versus%20docetaxel%20for%20previously%20treated%2C%20PD-L1-positive%2C%20advanced%20non-small-cell%20lung%20cancer%20%28KEYNOTE-010%29%3A%20a%20randomised%20controlled%20trial&journal=Lancet&doi=10.1016%2FS0140-6736%2815%2901281-7&volume=387&pages=1540-1550&publication_year=2016&author=Herbst%2CRS&author=Baas%2CP&author=Kim%2CDW&author=Felip%2CE&author=Perez-Gracia%2CJL&author=Han%2CJY&author=Molina%2CJ&author=Kim%2CJH&author=Arvis%2CCD&author=Ahn%2CMJ bring in each month?
- Get to know https://doi.org/10.1158%2F1078-0432.CCR-15-3101's earnings
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27225694 make?
- Financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026567
- How much does http://scholar.google.com/scholar_lookup?&title=EGFR%20mutations%20and%20ALK%20rearrangements%20are%20associated%20with%20low%20response%20rates%20to%20PD-1%20pathway%20blockade%20in%20non-small%20cell%20lung%20Cancer%3A%20a%20retrospective%20analysis&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-15-3101&volume=22&pages=4585-4593&publication_year=2016&author=Gainor%2CJF&author=Shaw%2CAT&author=Sequist%2CLV&author=Fu%2CX&author=Azzoli%2CCG&author=Piotrowska%2CZ&author=Huynh%2CTG&author=Zhao%2CL&author=Fulton%2CL&author=Schultz%2CKR bring in each month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28624922 net monthly?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20PD-1%2FPD-L1%20immune%20checkpoint%20in%20EGFR-mutated%20or%20ALK-Translocated%20non-small-cell%20lung%20Cancer&journal=Target%20Oncol&doi=10.1007%2Fs11523-017-0510-9&volume=12&pages=563-569&publication_year=2017&author=Bylicki%2CO&author=Paleiron%2CN&author=Margery%2CJ&author=Guisier%2CF&author=Vergnenegre%2CA&author=Robinet%2CG&author=Auliac%2CJB&author=Gervais%2CR&author=Chouaid%2CC
- How much does https://doi.org/10.1016%2FS1470-2045%2818%2930144-X rake in every month?
- Learn how profitable http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29545095 is on a monthly basis
- How much revenue does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771363 produce monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Durvalumab%20as%20third-line%20or%20later%20treatment%20for%20advanced%20non-small-cell%20lung%20cancer%20%28ATLANTIC%29%3A%20an%20open-label%2C%20single-arm%2C%20phase%202%20study&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2818%2930144-X&volume=19&pages=521-536&publication_year=2018&author=Garassino%2CMC&author=Cho%2CBC&author=Kim%2CJH&author=Mazieres%2CJ&author=Vansteenkiste%2CJ&author=Lena%2CH&author=Corral%20Jaime%2CJ&author=Gray%2CJE&author=Powderly%2CJ&author=Chouaid%2CC
- How much does https://doi.org/10.1016%2FS1470-2045%2818%2930160-8 make?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29545096?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=ATLANTIC%3A%20a%20sea%20change%20in%20immunotherapy%20for%20oncogene-driven%20lung%20cancer%3F&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2818%2930160-8&volume=19&pages=438-439&publication_year=2018&author=Lin%2CJJ&author=Gainor%2CJF each month?
- What's the revenue for https://doi.org/10.1158%2F2159-8290.CD-13-0310?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24078774?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Activation%20of%20the%20PD-1%20pathway%20contributes%20to%20immune%20escape%20in%20EGFR-driven%20lung%20tumors&journal=Cancer%20Discov&doi=10.1158%2F2159-8290.CD-13-0310&volume=3&pages=1355-1363&publication_year=2013&author=Akbay%2CEA&author=Koyama%2CS&author=Carretero%2CJ&author=Altabef%2CA&author=Tchaicha%2CJH&author=Christensen%2CCL&author=Mikse%2COR&author=Cherniack%2CAD&author=Beauchamp%2CEM&author=Pugh%2CTJ is on a monthly basis
- How much money does https://doi.org/10.1158%2F1535-7163.MCT-14-0548 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25504751 pull in?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Dual%20PI3K%2FmTOR%20inhibitors%2C%20GSK2126458%20and%20PKI-587%2C%20suppress%20tumor%20progression%20and%20increase%20radiosensitivity%20in%20nasopharyngeal%20carcinoma&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-14-0548&volume=14&pages=429-439&publication_year=2015&author=Liu%2CT&author=Sun%2CQ&author=Li%2CQ&author=Yang%2CH&author=Zhang%2CY&author=Wang%2CR&author=Lin%2CX&author=Xiao%2CD&author=Yuan%2CY&author=Chen%2CL&author=Wang%2CW
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26919104 earns monthly
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941313
- Earnings of http://scholar.google.com/scholar_lookup?&title=Hepatocyte%20growth%20factor%20reduces%20sensitivity%20to%20the%20epidermal%20growth%20factor%20receptor-tyrosine%20kinase%20inhibitor%2C%20gefitinib%2C%20in%20lung%20adenocarcinoma%20cells%20harboring%20wild-type%20EGFR&journal=Oncotarget&volume=7&pages=16273-16281&publication_year=2016&author=Yang%2CH&author=Wang%2CR&author=Peng%2CSL&author=Chen%2CLH&author=Li%2CQ&author=Wang%2CW
- Explore the financials of https://doi.org/10.1016%2Fj.ijrobp.2015.04.007
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26031366?
- How much does http://scholar.google.com/scholar_lookup?&title=MiR-20a%20induces%20cell%20Radioresistance%20by%20activating%20the%20PTEN%2FPI3K%2FAkt%20signaling%20pathway%20in%20hepatocellular%20carcinoma&journal=Int%20J%20Radiat%20Oncol%20Biol%20Phys&doi=10.1016%2Fj.ijrobp.2015.04.007&volume=92&pages=1132-1140&publication_year=2015&author=Zhang%2CY&author=Zheng%2CL&author=Ding%2CY&author=Li%2CQ&author=Wang%2CR&author=Liu%2CT&author=Sun%2CQ&author=Yang%2CH&author=Peng%2CS&author=Wang%2CW&author=Chen%2CL bring in each month?
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18979097
- How much money does http://scholar.google.com/scholar_lookup?&title=HM1.24%20%28CD317%29%20is%20a%20novel%20target%20against%20lung%20cancer%20for%20immunotherapy%20using%20anti-HM1.24%20antibody&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-008-0612-4&volume=58&pages=967-976&publication_year=2009&author=Wang%2CW&author=Nishioka%2CY&author=Ozaki%2CS&author=Jalili%2CA&author=Abe%2CS&author=Kakiuchi%2CS&author=Kishuku%2CM&author=Minakuchi%2CK&author=Matsumoto%2CT&author=Sone%2CS make?
- How much does https://doi.org/10.1074%2Fjbc.M114.612689 make?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25645920 net monthly?
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375468 earns monthly
- How much does http://scholar.google.com/scholar_lookup?&title=Novel%20roles%20of%20c-met%20in%20the%20survival%20of%20renal%20cancer%20cells%20through%20the%20regulation%20of%20HO-1%20and%20PD-L1%20expression&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M114.612689&volume=290&pages=8110-8120&publication_year=2015&author=Balan%2CM&author=Mier%20y%20Teran%2CE&author=Waaga-Gasser%2CAM&author=Gasser%2CM&author=Choueiri%2CTK&author=Freeman%2CG&author=Pal%2CS earn?
- See how much https://doi.org/10.1016%2Fj.biopha.2010.01.004 makes per month
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20382498 generate?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Vaccination%20with%20immature%20dendritic%20cells%20combined%20with%20CD40mAb%20induces%20protective%20immunity%20against%20B%20lymphoma%20in%20hu-SCID%20mice&journal=Biomed%20Pharmacother&doi=10.1016%2Fj.biopha.2010.01.004&volume=64&pages=487-492&publication_year=2010&author=Ge%2CY&author=Xi%2CH&author=Zhang%2CXG?
- How much does https://doi.org/10.1158%2F0008-5472.CAN-08-1643 rake in every month?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19010923 rake in every month?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Hepatocyte%20growth%20factor%20induces%20gefitinib%20resistance%20of%20lung%20adenocarcinoma%20with%20epidermal%20growth%20factor%20receptor-activating%20mutations&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-08-1643&volume=68&pages=9479-9487&publication_year=2008&author=Yano%2CS&author=Wang%2CW&author=Li%2CQ&author=Matsumoto%2CK&author=Sakurama%2CH&author=Nakamura%2CT&author=Ogino%2CH&author=Kakiuchi%2CS&author=Hanibuchi%2CM&author=Nishioka%2CY
- Find out how much https://doi.org/10.1038%2Fsj.onc.1203404 earns monthly
- Get to know what's the income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10713700
- How much profit is http://scholar.google.com/scholar_lookup?&title=Transcriptional%20activation%20of%20the%20hepatocyte%20growth%20factor%20receptor%20%28c-met%29%20gene%20by%20its%20ligand%20%28hepatocyte%20growth%20factor%29%20is%20mediated%20through%20AP-1&journal=Oncogene&doi=10.1038%2Fsj.onc.1203404&volume=19&pages=1132-1137&publication_year=2000&author=Seol%2CDW&author=Chen%2CQ&author=Zarnegar%2CR making per month?
- Financial intake of https://doi.org/10.1038%2Fnrc3239
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22437870
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856023?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=The%20blockade%20of%20immune%20checkpoints%20in%20cancer%20immunotherapy&journal=Nat%20Rev%20Cancer&doi=10.1038%2Fnrc3239&volume=12&pages=252-264&publication_year=2012&author=Pardoll%2CDM?
- What's the profit of https://doi.org/10.1016%2Fj.canlet.2015.02.043?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25727320?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Hepatocyte%20growth%20factor%20%28HGF%29%20upregulates%20heparanase%20expression%20via%20the%20PI3K%2FAkt%2FNF-kappaB%20signaling%20pathway%20for%20gastric%20cancer%20metastasis&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2015.02.043&volume=361&pages=57-66&publication_year=2015&author=Hao%2CNB&author=Tang%2CB&author=Wang%2CGZ&author=Xie%2CR&author=Hu%2CCJ&author=Wang%2CSM&author=Wu%2CYY&author=Liu%2CE&author=Xie%2CX&author=Yang%2CSM have monthly?
- What's the financial gain of https://doi.org/10.1038%2Fcddis.2015.66?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25906153
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650539 generate monthly?
- How much money does http://scholar.google.com/scholar_lookup?&title=NF-kappaB%20inhibition%20reveals%20a%20novel%20role%20for%20HGF%20during%20skeletal%20muscle%20repair&journal=Cell%20Death%20Dis&doi=10.1038%2Fcddis.2015.66&volume=6&publication_year=2015&author=Proto%2CJD&author=Tang%2CY&author=Lu%2CA&author=Chen%2CWC&author=Stahl%2CE&author=Poddar%2CM&author=Beckman%2CSA&author=Robbins%2CPD&author=Nidernhofer%2CLJ&author=Imbrogno%2CK make?
- What's the monthly money flow for https://doi.org/10.1158%2F1078-0432.CCR-11-1171?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22317763 generate monthly?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=Met%20kinase%20inhibitor%20E7050%20reverses%20three%20different%20mechanisms%20of%20hepatocyte%20growth%20factor-induced%20tyrosine%20kinase%20inhibitor%20resistance%20in%20EGFR%20mutant%20lung%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-11-1171&volume=18&pages=1663-1671&publication_year=2012&author=Wang%2CW&author=Li%2CQ&author=Takeuchi%2CS&author=Yamada%2CT&author=Koizumi%2CH&author=Nakamura%2CT&author=Matsumoto%2CK&author=Mukaida%2CN&author=Nishioka%2CY&author=Sone%2CS have monthly?
- What's the monthly money flow for https://doi.org/10.1158%2F1078-0432.CCR-12-2731?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23095323?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=The%20activation%20of%20MAPK%20in%20melanoma%20cells%20resistant%20to%20BRAF%20inhibition%20promotes%20PD-L1%20expression%20that%20is%20reversible%20by%20MEK%20and%20PI3K%20inhibition&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-12-2731&volume=19&pages=598-609&publication_year=2013&author=Jiang%2CX&author=Zhou%2CJ&author=Giobbie-Hurder%2CA&author=Wargo%2CJ&author=Hodi%2CFS?
- How much revenue does https://doi.org/10.1126%2Fscience.1141478 produce monthly?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17463250?
- How much does http://scholar.google.com/scholar_lookup?&title=MET%20amplification%20leads%20to%20gefitinib%20resistance%20in%20lung%20cancer%20by%20activating%20ERBB3%20signaling&journal=Science&doi=10.1126%2Fscience.1141478&volume=316&pages=1039-1043&publication_year=2007&author=Engelman%2CJA&author=Zejnullahu%2CK&author=Mitsudomi%2CT&author=Song%2CYC&author=Hyland%2CC&author=Park%2CJO&author=Lindeman%2CN&author=Gale%2CCM&author=Zhao%2CXJ&author=Christensen%2CJ gross monthly?
- How much revenue does https://doi.org/10.1073%2Fpnas.0710370104 produce monthly?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18093943?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409244 income
- How much does http://scholar.google.com/scholar_lookup?&title=MET%20amplification%20occurs%20with%20or%20without%20T790M%20mutations%20in%20EGFR%20mutant%20lung%20tumors%20with%20acquired%20resistance%20to%20gefitinib%20or%20erlotinib&journal=Proc%20Natl%20Acad%20Sci%20U%20S%20A&doi=10.1073%2Fpnas.0710370104&volume=104&pages=20932-20937&publication_year=2007&author=Bean%2CJ&author=Brennan%2CC&author=Shih%2CJY&author=Riely%2CG&author=Viale%2CA&author=Wang%2CL&author=Chitale%2CD&author=Motoi%2CN&author=Szoke%2CJ&author=Broderick%2CS bring in each month?
- Earnings of https://doi.org/10.1016%2Fj.bbrc.2015.05.030
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25998384 bring in each month?
- How much profit does http://scholar.google.com/scholar_lookup?&title=EGFR-TKI%20down-regulates%20PD-L1%20in%20EGFR%20mutant%20NSCLC%20through%20inhibiting%20NF-kappaB&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2015.05.030&volume=463&pages=95-101&publication_year=2015&author=Lin%2CK&author=Cheng%2CJ&author=Yang%2CT&author=Li%2CY&author=Zhu%2CB make?
- How much money does https://doi.org/10.1158%2F0008-5472.CAN-14-3510 make?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26113085's financial summary
- How much does http://scholar.google.com/scholar_lookup?&title=Nivolumab%20and%20Urelumab%20enhance%20antitumor%20activity%20of%20human%20T%20lymphocytes%20engrafted%20in%20Rag2%E2%88%92%2F%E2%88%92IL2Rgammanull%20Immunodeficient%20mice&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-14-3510&volume=75&pages=3466-3478&publication_year=2015&author=Sanmamed%2CMF&author=Rodriguez%2CI&author=Schalper%2CKA&author=Onate%2CC&author=Azpilikueta%2CA&author=Rodriguez-Ruiz%2CME&author=Morales-Kastresana%2CA&author=Labiano%2CS&author=Perez-Gracia%2CJL&author=Martin-Algarra%2CS gross monthly?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27552968?
- What's the revenue for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995750?
- How much money does http://scholar.google.com/scholar_lookup?&title=Prognostic%20impact%20of%20programed%20cell%20death-1%20%28PD-1%29%20and%20PD-ligand%201%20%28PD-L1%29%20expression%20in%20cancer%20cells%20and%20tumor%20infiltrating%20lymphocytes%20in%20colorectal%20cancer&journal=Mol%20Cancer&doi=10.1186%2Fs12943-016-0539-x&volume=15&publication_year=2016&author=Li%2CY&author=Liang%2CL&author=Dai%2CW&author=Cai%2CG&author=Xu%2CY&author=Li%2CX&author=Li%2CQ&author=Cai%2CS generate?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28550387's gross income?
- See how much http://scholar.google.com/scholar_lookup?&title=Correlation%20of%20c-MET%20expression%20with%20PD-L1%20expression%20in%20metastatic%20clear%20cell%20renal%20cell%20carcinoma%20treated%20by%20Sunitinib%20first-line%20therapy&journal=Target%20Oncol&doi=10.1007%2Fs11523-017-0498-1&volume=12&pages=487-494&publication_year=2017&author=Kammerer-Jacquet%2CSF&author=Medane%2CS&author=Bensalah%2CK&author=Bernhard%2CJC&author=Yacoub%2CM&author=Dupuis%2CF&author=Ravaud%2CA&author=Verhoest%2CG&author=Mathieu%2CR&author=Peyronnet%2CB makes per month
- Financial intake of https://doi.org/10.1093%2Fannonc%2Fmdx183
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28407039?
- How much does http://scholar.google.com/scholar_lookup?&title=Tumor%20immune%20microenvironment%20and%20nivolumab%20efficacy%20in%20EGFR%20mutation-positive%20non-small-cell%20lung%20cancer%20based%20on%20T790M%20status%20after%20disease%20progression%20during%20EGFR-TKI%20treatment&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdx183&volume=28&pages=1532-1539&publication_year=2017&author=Haratani%2CK&author=Hayashi%2CH&author=Tanaka%2CT&author=Kaneda%2CH&author=Togashi%2CY&author=Sakai%2CK&author=Hayashi%2CK&author=Tomida%2CS&author=Chiba%2CY&author=Yonesaka%2CK pull in?
- What's the monthly income of https://doi.org/10.1200%2FJCO.2014.58.3708?
- How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25897158 earning monthly?
- How much profit is http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672027 making per month?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Overall%20survival%20and%20long-term%20safety%20of%20Nivolumab%20%28anti-programmed%20death%201%20antibody%2C%20BMS-936558%2C%20ONO-4538%29%20in%20patients%20with%20previously%20treated%20advanced%20non-small-cell%20lung%20Cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2014.58.3708&volume=33&pages=2004-2012&publication_year=2015&author=Gettinger%2CSN&author=Horn%2CL&author=Gandhi%2CL&author=Spigel%2CDR&author=Antonia%2CSJ&author=Rizvi%2CNA&author=Powderly%2CJD&author=Heist%2CRS&author=Carvajal%2CRD&author=Jackman%2CDM?
- How much does https://doi.org/10.1056%2FNEJMoa1200690 net monthly?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22658127 make?
- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544539's total income per month
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Safety%2C%20activity%2C%20and%20immune%20correlates%20of%20anti-PD-1%20antibody%20in%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1200690&volume=366&pages=2443-2454&publication_year=2012&author=Topalian%2CSL&author=Hodi%2CFS&author=Brahmer%2CJR&author=Gettinger%2CSN&author=Smith%2CDC&author=McDermott%2CDF&author=Powderly%2CJD&author=Carvajal%2CRD&author=Sosman%2CJA&author=Atkins%2CMB?
- How much money does https://doi.org/10.1056%2FNEJMoa1504627 make?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26028407 generate?
- Learn how profitable http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681400 is on a monthly basis
- How much does http://scholar.google.com/scholar_lookup?&title=Nivolumab%20versus%20Docetaxel%20in%20advanced%20squamous-cell%20non-small-cell%20lung%20Cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1504627&volume=373&pages=123-135&publication_year=2015&author=Brahmer%2CJ&author=Reckamp%2CKL&author=Baas%2CP&author=Crino%2CL&author=Eberhardt%2CWE&author=Poddubskaya%2CE&author=Antonia%2CS&author=Pluzanski%2CA&author=Vokes%2CEE&author=Holgado%2CE rake in every month?
- How much does https://doi.org/10.1084%2Fjem.20161462 net monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27903604 have monthly?
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154949?
- Revenue of http://scholar.google.com/scholar_lookup?&title=What%20does%20PD-L1%20positive%20or%20negative%20mean%3F&journal=J%20Exp%20Med&doi=10.1084%2Fjem.20161462&volume=213&pages=2835-2840&publication_year=2016&author=Ribas%2CA&author=Hu-Lieskovan%2CS
- How much does https://doi.org/10.1016%2Fj.cell.2014.12.033 make?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25594174 generate?
- Earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856474
- Get to know http://scholar.google.com/scholar_lookup?&title=Molecular%20and%20genetic%20properties%20of%20tumors%20associated%20with%20local%20immune%20cytolytic%20activity&journal=Cell&doi=10.1016%2Fj.cell.2014.12.033&volume=160&pages=48-61&publication_year=2015&author=Rooney%2CMS&author=Shukla%2CSA&author=Wu%2CCJ&author=Getz%2CG&author=Hacohen%2CN's earnings
- How much does https://doi.org/10.1016%2FS2213-2600%2819%2930084-0 make?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=30922878?
- How much income is http://scholar.google.com/scholar_lookup?&title=Atezolizumab%20plus%20bevacizumab%20and%20chemotherapy%20in%20non-small-cell%20lung%20cancer%20%28IMpower150%29%3A%20key%20subgroup%20analyses%20of%20patients%20with%20EGFR%20mutations%20or%20baseline%20liver%20metastases%20in%20a%20randomised%2C%20open-label%20phase%203%20trial&journal=Lancet%20Respir%20Med&doi=10.1016%2FS2213-2600%2819%2930084-0&volume=7&pages=387-401&publication_year=2019&author=Reck%2CM&author=Mok%2CTSK&author=Nishio%2CM&author=Jotte%2CRM&author=Cappuzzo%2CF&author=Orlandi%2CF&author=Stroyakovskiy%2CD&author=Nogami%2CN&author=Rodriguez-Abreu%2CD&author=Moro-Sibilot%2CD earning monthly?
- Learn how profitable https://citation-needed.springer.com/v2/references/10.1186/s12943-019-1073-4?format=refman&flavour=references is on a monthly basis
- What are the earnings of http://www.letpub.com?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shunli%20Peng earn?
- What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shunli%20Peng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Rong%20Wang make?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Rong%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xiaojuan%20Zhang have?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xiaojuan%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yueyun%20Ma
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yueyun%20Ma%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Longhui%20Zhong generate monthly?
- What's the monthly income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Longhui%20Zhong%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ke%20Li?
- What are the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ke%20Li%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Akihiro%20Nishiyama income
- What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Akihiro%20Nishiyama%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Sachiko%20Arai
- How much income is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Sachiko%20Arai%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earning monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Seiji%20Yano earn?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Seiji%20Yano%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much income does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Wei%20Wang have?
- Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Wei%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Financial intake of https://static-content.springer.com/esm/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_MOESM1_ESM.docx
- How much revenue does https://static-content.springer.com/esm/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_MOESM2_ESM.pdf bring in?
- What's the income of https://static-content.springer.com/esm/art%3A10.1186%2Fs12943-019-1073-4/MediaObjects/12943_2019_1073_MOESM3_ESM.docx?
- What's the profit of http://creativecommons.org/licenses/by/4.0/?
- How much does http://creativecommons.org/publicdomain/zero/1.0/ pull in monthly?
- https://s100.copyright.com/AppDispatchServlet?title=EGFR-TKI%20resistance%20promotes%20immune%20escape%20in%20lung%20cancer%20via%20increased%20PD-L1%20expression&author=Shunli%20Peng%20et%20al&contentID=10.1186%2Fs12943-019-1073-4©right=The%20Author%28s%29.&publication=1476-4598&publicationDate=2019-11-20&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY%20%2B%20CC0's financial summary
- What's the financial gain of https://crossmark.crossref.org/dialog/?doi=10.1186/s12943-019-1073-4?
- How much does https://citation-needed.springer.com/v2/references/10.1186/s12943-019-1073-4?format=refman&flavour=citation net monthly?
- What are the total earnings of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral?
- Financial intake of https://www.springernature.com/gp/products
- https://www.springernature.com/gp/librarians income
- How much income is https://www.springernature.com/gp/societies earning monthly?
- Monthly income for https://www.springernature.com/gp/partners
- How much profit does https://www.springer.com/ generate?
- Income figures for https://www.nature.com/
- Profit of https://www.biomedcentral.com/
- How much profit does https://www.palgrave.com/ make?
- Earnings of https://www.apress.com/
- How much revenue does https://www.springernature.com/gp/legal/ccpa produce monthly?
- How profitable is https://www.springernature.com/gp/info/accessibility?
- How much revenue does https://support.springernature.com/en/support/home bring in?
- What is the earnings of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- How much money does https://www.springernature.com/ make?
Analytics and Tracking {š}
- Google Tag Manager
Libraries {š}
- Clipboard.js
- Prism.js
CDN Services {š¦}
- Crossref